Dataset Information

Geographic variation of mutagenic exposures in kidney cancer genomes

ABSTRACT:

International differences in the incidence of many cancer types indicate the existence of carcinogen exposures that have not been identified by conventional epidemiology yet potentially make a substantial contribution to cancer burden1. This pertains to clear cell renal cell carcinoma (ccRCC), for which obesity, hypertension, and tobacco smoking are risk factors but do not explain its geographical variation in incidence2. Some carcinogens generate somatic mutations and a complementary strategy for detecting past exposures is to sequence the genomes of cancers from populations with different incidence rates and infer underlying causes from differences in patterns of somatic mutations. Here, we sequenced 962 ccRCC from 11 countries of varying incidence. Somatic mutation profiles differed between countries. In Romania, Serbia and Thailand, mutational signatures likely caused by extracts of Aristolochia plants were present in most cases and rare elsewhere. In Japan, a mutational signature of unknown cause was found in >70% cases and <2% elsewhere. A further mutational signature of unknown cause was ubiquitous but exhibited higher mutation loads in countries with higher kidney cancer incidence rates (p-value <6 × 10−18). Known signatures of tobacco smoking correlated with tobacco consumption, but no signature was associated with obesity or hypertension suggesting non-mutagenic mechanisms of action underlying these risk factors. The results indicate the existence of multiple, geographically variable, mutagenic exposures potentially affecting 10s of millions of people and illustrate the opportunities for new insights into cancer causation through large-scale global cancer genomics.

Linked cross omic data sets:

Geographic variation of mutagenic exposures in kidney cancer genomes – patient metadata files (Mutographs) associated with this study are available in the European Genome-Phenome Archive: https://ega-archive.org/datasets/EGAD00001012223.

INSTRUMENT(S): Liquid Chromatography MS - positive - reverse phase

SUBMITTER: Thomas Cattiaux

PROVIDER: MTBLS9394 | MetaboLights | 2024-03-26

REPOSITORIES: MetaboLights

ACCESS DATA

Dataset's files

Source:

			Action	DRS
	MTBLS9394	Other
	FILES	Other
	a_MTBLS9394_LC-MS_positive_reverse-phase_metabolite_profiling.txt	Txt
	i_Investigation.txt	Txt
	m_MTBLS9394_LC-MS_positive_reverse-phase_metabolite_profiling_v2_maf.tsv	Tabular

Items per page:

1 - 5 of 6

Publications

Geographic variation of mutagenic exposures in kidney cancer genomes.

Senkin Sergey S Moody Sarah S Díaz-Gay Marcos M Abedi-Ardekani Behnoush B Cattiaux Thomas T Ferreiro-Iglesias Aida A Wang Jingwei J Fitzgerald Stephen S Kazachkova Mariya M Vangara Raviteja R Le Anh Phuong AP Bergstrom Erik N EN Khandekar Azhar A Otlu Burçak B Cheema Saamin S Latimer Calli C Thomas Emily E Atkins Joshua Ronald JR Smith-Byrne Karl K Cortez Cardoso Penha Ricardo R Carreira Christine C Chopard Priscilia P Gaborieau Valérie V Keski-Rahkonen Pekka P Jones David D Teague Jon W JW Ferlicot Sophie S Asgari Mojgan M Sangkhathat Surasak S Attawettayanon Worapat W Świątkowska Beata B Jarmalaite Sonata S Sabaliauskaite Rasa R Shibata Tatsuhiro T Fukagawa Akihiko A Mates Dana D Jinga Viorel V Rascu Stefan S Mijuskovic Mirjana M Savic Slavisa S Milosavljevic Sasa S Bartlett John M S JMS Albert Monique M Phouthavongsy Larry L Ashton-Prolla Patricia P Botton Mariana R MR Silva Neto Brasil B Bezerra Stephania Martins SM Curado Maria Paula MP Zequi Stênio de Cássio SC Reis Rui Manuel RM Faria Eliney Ferreira EF de Menezes Nei Soares NS Ferrari Renata Spagnoli RS Banks Rosamonde E RE Vasudev Naveen S NS Zaridze David D Mukeriya Anush A Shangina Oxana O Matveev Vsevolod V Foretova Lenka L Navratilova Marie M Holcatova Ivana I Hornakova Anna A Janout Vladimir V Purdue Mark P MP Rothman Nathaniel N Chanock Stephen J SJ Ueland Per Magne PM Johansson Mattias M McKay James J Scelo Ghislaine G Chanudet Estelle E Humphreys Laura L de Carvalho Ana Carolina AC Perdomo Sandra S Alexandrov Ludmil B LB Stratton Michael R MR Brennan Paul P

Nature 20240501 8013

International differences in the incidence of many cancer types indicate the existence of carcinogen exposures that have not yet been identified by conventional epidemiology make a substantial contribution to cancer burden<sup>1</sup>. In clear cell renal cell carcinoma, obesity, hypertension and tobacco smoking are risk factors, but they do not explain the geographical variation in its incidence<sup>2</sup>. Underlying causes can be inferred by sequencing the genomes of cancers from populations ...[more]

PMID: 38693263

Similar Datasets

Project description:As part of current harm reduction strategies, candidate modified risk tobacco products (MRTP)s are developed to offer adult smokers who want to continue using tobacco products as an alternative to cigarettes while potentially reducing individual risk and population harm compared to smoking cigarettes. One of these candidate MRTPs is the Tobacco Heating System (THS) 2.2 which does not burn tobacco, but instead heats it, thus producing significantly reduced levels of harmful and potentially harmful constituents (HPHC)s compared with combustible cigarettes (CC). The assessment of MRTPs against combustible cigarettes requires the establishment of exposure-response markers. Biomarkers derived from blood offer for the general population a less invasive alternative than sampling the primary site, such as the airways. Various diseases and exposures, including cigarette smoke, have been shown to alter the molecular profile of the blood. Leveraging this fact, a whole blood derived gene signature that can distinguish current smokers from either non-smokers or former smokers with high specificity and sensitivity was previously reported. Four controlled, parallel randomized groups, open-label clinical studies were conducted with subjects randomized to three groups: (1) switching from CCs to THS2.2 (or its mentholated version, respectively); (2) continuous use of CC; or (3) smoking abstinence. These studies had an investigational period of five days in confinement which was followed by an 85 day ambulatory period for two of them. By measuring biomarkers of exposure to selected HPHCs, these studies showed a consistent reduced exposure in subjects that either stopped smoking or switched to THS2.2 (including mentholated version), compared with subjects who continued smoking their own cigarettes at both day 5 and at day 90. To complement the classical exposure measurements, we tested the small signature consisting of only 11 genes on the blood transcriptome of subjects enrolled in the clinical studies. We show that in all four clinical studies tested, the signature scores were consistently reduced in subjects that either stopped smoking or switched to THS2.2 compared with subjects who continued smoking their conventional tobacco products at both day 6 and at day 91.

Project description:Esophageal cancer is among the 10 most common malignancies and ranks as the 6th leading cause of death from cancer. It constitutes 7% of all gastrointestinal cancers and is one of the most lethal of all cancers. The large variation in the incidence of esophageal cancer in different geographic regions has often been thought to be due to variation in exposure to environmental factors; however, hereditary factors may also contribute to the variation in rates. A positive family history was found to be associated with an increased risk of esophageal cancer in several case-control and cohort studies in China. Familial aggregation also has been observed in Iran and Japan. The cancer data generated from six hospital based cancer registries in India under National Cancer Registry Programme (NCRP, Annual Report, 2003-2004) has revealed that the occurrence of esophageal cancer in Assam is highest in India. The aggregation of esophageal cancer in families is a long-observed and well-documented phenomenon in Assam of North-east part of India (AAR=32.6). In Assam high incidence of esophageal cancer with familial aggregation need investigation for etiology. The etiology of esophageal cancer in Northeast Indian population is different from other population at India due to wide variations in dietary habits or nutritional factors, tobacco chewing and alcohol habits. With in these high-risk regions, studies have shown a strong tendency toward familial aggregation, suggesting that genetic susceptibility, in conjunction with potential environmental exposures, may be involved in the etiology of esophageal cancer. Familial clustering of cancer has been one of the main avenues to the understanding of cancer etiology and the signal to the involvement of heritable genes. Familial clustering of cancer may be due to environmental factors shared by family members or due to shared genes. However, the familial aggregation of esophageal cancer among the population in northeast India may reflect the influence of environmental factors operating on individuals who are already genetically susceptible. Epidemiological studies indicate that tobacco smoking and alcohol consumption are the major factors for esophageal cancer, the role of genetic factors for familial aggregation has not been elucidated. In this study, tumor and matched normal tissue from esophageal squamous cell carcinoma patients with a family history of upper gastrointestinal cancer were analyzed using cDNA microarray containing 10,000genes to evaluate gene expression differences in esophageal squamous cell carcinoma patients with a family history of upper gastrointestinal cancer from a high- risk area in India. To identify alteration in genes and molecular functional pathways in esophageal cancer in a high incidence region of India where there is wide spread use of tobacco and betel quid with fermented areca nuts and familial aggregation cancer. Keywords: Gene Expression